BCAX CIK: 2023658

Bicara Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25

Assets

(positive)
Change from FY23 to FY25
millions USD
FY23:
231
FY24:
503
FY25:
422
(positive)
Change from FY23 to FY25
millions USD
FY23:
2.91
FY24:
7.46
FY25:
8.94
Total assets
Change from FY23 to FY25
millions USD
FY23:
234
FY24:
510
FY25:
431

Liabilities & Equity

(negative)
Change from FY23 to FY25
millions USD
FY23:
15.1
FY24:
18.0
FY25:
28.9
(negative)
Change from FY23 to FY25
millions USD
FY23:
0.39
FY24:
0.13
FY25:
0.59
(positive)
Change from FY23 to FY25
millions USD
FY23:
−149
FY24:
492
FY25:
401
Total liabilities & equity
Change from FY24 to FY25
millions USD
FY23:
–
FY24:
510
FY25:
431

All amounts in millions USD Data sources:SEC EDGARTwelve Data